In August of this year, the BCM3 antibody intermediate and conjugated stock solution dual-function production line and DP4 formulation workshop at the Singapore production site of Pharmaceutical Contract Research, Development and Production Outsourcing Company Pharmaceuticals were approved by GMP. This is the company's first overseas production site to be approved by GMP.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.